microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.
about
Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesisDiagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative StressRole of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismMicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal HemoglobinmiRNA Influences in NRF2 Pathway Interactions within Cancer ModelsAntioxidant responses and cellular adjustments to oxidative stressNoncoding RNAs in DNA repair and genome integrityBiomarkers and recent advances in the management and therapy of sickle cell diseaseEpigenetic regulation of Keap1-Nrf2 signalingThe complexity of the Nrf2 pathway: beyond the antioxidant responseHealth promoting effects of brassica-derived phytochemicals: from chemopreventive and anti-inflammatory activities to epigenetic regulationMiR-214 promotes the alcohol-induced oxidative stress via down-regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cellsHigh-throughput sequencing of microRNA transcriptome and expression assay in the sturgeon, Acipenser schrenckiiSubstrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes.Plasma microRNA expression and micronuclei frequency in workers exposed to polycyclic aromatic hydrocarbonsCaloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats.MiR-28 regulates Nrf2 expression through a Keap1-independent mechanismAcidosis induces reprogramming of cellular metabolism to mitigate oxidative stress.MicroRNA-376a regulates 78-kilodalton glucose-regulated protein expression in rat granulosa cells.Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.Iron-responsive miR-485-3p regulates cellular iron homeostasis by targeting ferroportin.MIR144 and MIR451 regulate human erythropoiesis via RAB14Hypoxia-induced miR-15a promotes mesenchymal ablation and adaptation to hypoxia during lung development in chicken.Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.Trpc2 depletion protects red blood cells from oxidative stress-induced hemolysis.Emerging EPO and EPO receptor regulators and signal transducers.A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes.Common patterns and disease-related signatures in tuberculosis and sarcoidosisPhase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell DiseaseIdentification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance.Targeting of Gamma-Glutamyl-Cysteine Ligase by miR-433 Reduces Glutathione Biosynthesis and Promotes TGF-β-Dependent Fibrogenesis.MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells.Mild hyperthermia enhances the expression and induces oscillations in the Dicer protein.Protective Effects of L-Malate against Myocardial Ischemia/Reperfusion Injury in RatsBeyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyHydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell diseaseA systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease
P2860
Q24810377-DA927593-7265-4CFB-9941-E1E572BDB786Q26744498-C7E56140-594F-44C6-964E-41E4A53F531AQ26751266-FCE2B748-4AEC-4A38-A8AA-23761745DD69Q26766931-CD29136D-CFCB-4A3B-8ADD-78E7B710E4A1Q26783311-9C3C5178-85CC-4104-B1F6-14599BDD4D59Q26800229-4965745F-4EA9-407D-83EE-90D320852357Q26864697-D32A42C6-5467-4602-8719-C3B3FFB2EC17Q28082462-D5B63ED1-88AB-4D4E-B4FE-BEB236BA05C1Q28084220-29D85A1B-82B5-49E1-B687-92B1E0D2791CQ28389296-5CB9F658-D2A7-42B6-A956-19F54C80BF60Q28393960-7239A100-8449-49B9-BB3E-836CFEF9062EQ28569223-25567A49-92D3-4A6C-A955-2111DAC6A9AEQ28649789-E27C15B4-11CE-42E0-BF42-C9A8CD90693DQ33715549-01EF6AF7-7BD5-45F6-A58B-812729A91706Q33840993-ACAB6746-F247-481E-816C-66F31FFADBDFQ34001695-C6952662-7215-4B16-9CEF-7CC0E76FFDBAQ34189586-E548E1D6-DE9A-455C-9E28-C1003773D2D7Q34258940-E6DF6D8B-339C-4444-9C8D-C6E891F1ED3AQ34287267-8199FF6F-4431-47EF-8770-023E7B6536BAQ34632505-B01B2B13-7933-4308-9B48-6FBFE5ECBD52Q34671956-0C68D7EA-81CB-46C4-B2FA-CA176F26C475Q35039945-D2269BFD-BE12-48A7-BB8E-EC90EA773DC9Q35179724-E526E922-8150-4836-ACC3-2D44358D49F4Q35553378-33475F47-CEE8-463A-8D76-986ABBDECF96Q35613275-D3ED28AD-B904-45B7-8AF0-4655008D7430Q35692391-02F7848E-10CB-402A-BF32-84EDD3A24198Q35842890-14D27F57-9754-4625-A1D4-C5CD8721C04EQ35974078-B6AD06D3-4030-4DF3-A642-DF1D1B21B8FCQ35987429-20C88FD3-D9D3-4C43-9491-4B4056672338Q36180243-42FE1323-5284-49D1-AC6E-E1A4289B383EQ36233996-0003EE9E-5894-4B72-8EEA-712D4B1C64CAQ36311399-9EFE58FD-7DE1-4ADC-A520-C96DA85FB1C7Q36319102-12B47CE3-1496-4032-9E99-8DCE685B8FA3Q36454075-6912BCDE-629C-4AE8-84DF-01AB0A2BDB27Q36555717-84651E2B-88D0-4FC8-AC1D-ABEE5C8BBE87Q36578366-E84D3143-FBDD-46DB-AAE0-0FDA2C0C6779Q36596855-9B98BCB5-83DB-4221-B629-37F1D6D4F661Q36618667-A1528CCB-48E7-4009-81FC-82C626408603Q36777717-F0FA8709-1C61-455E-BFF6-1C4EF35E2A8FQ36792555-E3E110A9-1C73-435A-9ECB-A3D89161BC86
P2860
microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@ast
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@en
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@nl
type
label
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@ast
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@en
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@nl
prefLabel
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@ast
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@en
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@nl
P2093
P2860
P1433
P1476
microRNA miR-144 modulates oxi ...... verity in sickle cell disease.
@en
P2093
Carolyn Sangokoya
Jen-Tsan Chi
Marilyn J Telen
P2860
P304
P356
10.1182/BLOOD-2009-04-214817
P407
P577
2010-08-13T00:00:00Z